For MZ SR:
- director-General Department of Pharmacy and Drug Policy MUDr. Adam Hlôška
- director of the Department of Classification, Pricing and Drug Policy PharmDr. Rastislav Pullmann
- iVDr. Erica Hanzelya
For GSK:
- MUDr. Pavol Trnovec
The meeting was held at the request of the Director-General of the Section
pharmacy and drug policy MUDr. Adama Hlôška.
The meeting was opened by the Director General of the Department of Pharmacy and Drug Policy
Dr. Adam Hlôška.
MZ SR
The reason for the meeting is the situation with the availability of GSK vaccines. The Ministry expects the company to process the import and distribution of vaccines for the last two years.
GSK
The company will send processed data to the Ministry for the last week two years for Infanrix Hexa, Boostrix polio, Priorix. Listed data will be in the structure of imports to the Slovak Republic, sales to distribution networks compared to 2014/2015.
The sitting was closed by the Director-General of the Department of Pharmacy and Drug Policy Dr Adam Hlôška
|
She wrote: |
Mr Erika Hanzely |